The role of chronic kidney disease in assessing the risk of the poor course of hospital ST-segment elevation myocardial infarction

by V N Karetnikova, V V Kalaeva, M V Evseeva, A V Osokina, V V Kashtalap, O V Gruzdeva, K S Shafranskaya, M V Zykov, O L Barbarash
Published 2016-06-01

Renal function estimation formulas in predicting long-term cardiovascular outcomes in patients with myocardial infarction concurrent with diabetes mellitus

by V N Karetnikova, A V Osokina, M V Evseeva, V V Kalaeva, O V Gruzdeva, V V Kashtalap, M V Zykov, O E Avramenko, O L Barbarash
Published 2016-04-01

Do the patients with peripheral atherosclerosis need to a medical therapy before the revascularization?

by O L Barbarash, V V Kashtalap
Published 2019-12-01

Diagnostic value of the stimulating growth factor ST2 during hospitalization for myocardial infarction

by O V Gruzdeva, O E Akbasheva, E G Uchasova, Yu A Dyleva, N V Fedorova, V N Karetnikova, V V Kashtalap, O L Barbarash
Published 2016-04-01

Myocardial fibrosis: Current aspects of the problem

by V N Karetnikova, V V Kashtalap, S N Kosareva, O L Barbarash
Published 2017-01-01